Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Stuurman AL, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ.

BMC Infect Dis. 2016 Jun 8;16:257. doi: 10.1186/s12879-016-1549-4.

2.

Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Sandgren A, Vonk Noordegraaf-Schouten M, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ.

BMC Infect Dis. 2016 May 17;16:204. doi: 10.1186/s12879-016-1550-y.

3.

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S; ERLTB-Net Network.

PLoS One. 2016 Apr 7;11(4):e0152926. doi: 10.1371/journal.pone.0152926. eCollection 2016.

4.

Public health needs of migrants, refugees and asylum seekers in Europe, 2015: Infectious disease aspects.

Semenza JC, Carrillo-Santisteve P, Zeller H, Sandgren A, van der Werf MJ, Severi E, Pastore Celentano L, Wiltshire E, Suk JE, Dinca I, Noori T, Kramarz P.

Eur J Public Health. 2016 Jun;26(3):372-3. doi: 10.1093/eurpub/ckw023. Epub 2016 Apr 6. No abstract available.

PMID:
27053729
5.

Tuberculosis infection control in health facilities in Lithuania: lessons learnt from a capacity support project.

Turusbekova N, Ljungqvist I, Davidavičiene E, Mikaityte J, van der Werf MJ.

Public Health Action. 2016 Mar 21;6(1):22-4. doi: 10.5588/pha.15.0060.

6.

Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.

Ködmön C, Zucs P, van der Werf MJ.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30164.

PMID:
27039665
7.

Impact of migration on tuberculosis epidemiology and control in the EU/EEA.

van der Werf MJ, Zellweger JP.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30174. No abstract available.

PMID:
27035852
8.

The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.

Hollo V, Kotila SM, Ködmön C, Zucs P, van der Werf MJ.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171.

PMID:
27035746
9.

Interrupted BCG vaccination is a major threat to global child health.

Marais BJ, Seddon JA, Detjen AK, van der Werf MJ, Grzemska M, Hesseling AC, Curtis N, Graham SM; WHO Child TB Subgroup.

Lancet Respir Med. 2016 Apr;4(4):251-3. doi: 10.1016/S2213-2600(16)00099-0. Epub 2016 Mar 23. No abstract available.

PMID:
27016867
10.

Tackling tuberculosis in migrants.

van der Werf MJ, Kramarz P.

Lancet Infect Dis. 2016 Aug;16(8):877-8. doi: 10.1016/S1473-3099(16)00148-1. Epub 2016 Mar 22. No abstract available.

11.

Strengthening TB infection control in specialized health facilities in Romania--using a participatory approach.

Turusbekova N, Popa C, Dragos M, van der Werf MJ, Dinca I.

Public Health. 2016 Feb;131:75-81. doi: 10.1016/j.puhe.2015.10.031. Epub 2016 Jan 15.

12.

Impact of HIV infection on treatment outcome of tuberculosis in Europe.

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W.

AIDS. 2016 Apr 24;30(7):1089-98. doi: 10.1097/QAD.0000000000001016.

PMID:
26752278
13.

Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W.

Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087. Erratum in: Euro Surveill. 2015;20(50). doi: 10.2807/1560-7917.ES.2015.20.50.30092.

PMID:
26676247
14.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24.

15.

Progressing towards tuberculosis elimination in the European Union and European Economic Area.

van der Werf MJ, Antoine D.

Euro Surveill. 2015 Mar 19;20(11). pii: 21066. No abstract available.

16.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

17.

Pre-entry, post-entry, or no tuberculosis screening?

van der Werf MJ, Lönnroth K.

Lancet Infect Dis. 2014 Dec;14(12):1171-2. doi: 10.1016/S1473-3099(14)70998-3. Epub 2014 Nov 7. No abstract available.

18.

Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation.

Migliori GB, Lienhardt C, Weyer K, van der Werf MJ, Blasi F, Raviglione MC.

Eur Respir J. 2014 Dec;44(6):1412-7. doi: 10.1183/09031936.00132114. No abstract available.

19.

The European Union standards for tuberculosis care: do they need an update?

van der Werf MJ, Sandgren A, D'Ambrosio L, Blasi F, Migliori GB.

Eur Respir J. 2014 Apr;43(4):933-42. doi: 10.1183/09031936.00216613. No abstract available.

20.

Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011.

De Beer JL, Kodmon C, van der Werf MJ, van Ingen J, van Soolingen D; ECDC MDR-TB Molecular Surveillance Project Participants.

Euro Surveill. 2014 Mar 20;19(11). pii: 20742.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk